• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞衍生的外泌体作为微 RNA 递药系统在不同疾病中的潜在应用。

The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases.

机构信息

Department of Pharmaceutical Science, Azad Islamic University of Medical Sciences, Tehran, Iran.

Department of Molecular Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Cell Commun Signal. 2023 Jan 23;21(1):20. doi: 10.1186/s12964-022-01017-9.

DOI:10.1186/s12964-022-01017-9
PMID:36690996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9869323/
Abstract

MicroRNAs (miRNAs) are a group of small non-coding RNAs that regulate gene expression by targeting mRNA. Moreover, it has been shown that miRNAs expression are changed in various diseases, such as cancers, autoimmune disease, infectious diseases, and neurodegenerative Diseases. The suppression of miRNA function can be easily attained by utilizing of anti-miRNAs. In contrast, an enhancement in miRNA function can be achieved through the utilization of modified miRNA mimetics. The discovery of appropriate miRNA carriers in the body has become an interesting subject for investigators. Exosomes (EXOs) therapeutic efficiency and safety for transferring different cellular biological components to the recipient cell have attracted significant attention for their capability as miRNA carriers. Mesenchymal stem cells (MSCs) are recognized to generate a wide range of EXOs (MSC-EXOs), showing that MSCs may be effective for EXO generation in a clinically appropriate measure as compared to other cell origins. MSC-EXOs have been widely investigated because of their immune attributes, tumor-homing attributes, and flexible characteristics. In this article, we summarized the features of miRNAs and MSC-EXOs, including production, purification, and miRNA loading methods of MSC-EXOs, and the modification of MSC-EXOs for targeted miRNA delivery in various diseases. Video abstract.

摘要

微小 RNA(miRNAs)是一组小的非编码 RNA,通过靶向 mRNA 来调节基因表达。此外,已经表明 miRNAs 的表达在各种疾病中发生改变,如癌症、自身免疫性疾病、传染病和神经退行性疾病。利用抗 miRNAs 可以很容易地抑制 miRNA 的功能。相比之下,可以通过利用修饰的 miRNA 模拟物来增强 miRNA 的功能。在体内发现合适的 miRNA 载体已成为研究人员感兴趣的课题。外泌体(EXOs)在将不同的细胞生物成分传递给受体细胞方面具有治疗效率和安全性,因此作为 miRNA 载体引起了广泛关注。间充质干细胞(MSCs)被认为会产生广泛的 EXOs(MSC-EXOs),这表明与其他细胞来源相比,MSCs 可能更适合作为 EXO 的生成,以达到临床适当的程度。MSC-EXOs 因其免疫属性、肿瘤归巢属性和灵活特性而得到广泛研究。在本文中,我们总结了 miRNAs 和 MSC-EXOs 的特征,包括 MSC-EXOs 的产生、纯化和 miRNA 加载方法,以及 MSC-EXOs 用于各种疾病中靶向 miRNA 递释的修饰。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/cdcf464756fe/12964_2022_1017_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/294bb3a7b14c/12964_2022_1017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/f2a673819634/12964_2022_1017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/d966e3d59ad2/12964_2022_1017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/380ad152497e/12964_2022_1017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/1fa86067fd0f/12964_2022_1017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/b13fb7beab7c/12964_2022_1017_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/15ab004708e6/12964_2022_1017_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/e55fac40d62b/12964_2022_1017_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/cdcf464756fe/12964_2022_1017_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/294bb3a7b14c/12964_2022_1017_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/f2a673819634/12964_2022_1017_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/d966e3d59ad2/12964_2022_1017_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/380ad152497e/12964_2022_1017_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/1fa86067fd0f/12964_2022_1017_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/b13fb7beab7c/12964_2022_1017_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/15ab004708e6/12964_2022_1017_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/e55fac40d62b/12964_2022_1017_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7844/9869637/cdcf464756fe/12964_2022_1017_Fig9_HTML.jpg

相似文献

1
The potential use of mesenchymal stem cells-derived exosomes as microRNAs delivery systems in different diseases.间充质干细胞衍生的外泌体作为微 RNA 递药系统在不同疾病中的潜在应用。
Cell Commun Signal. 2023 Jan 23;21(1):20. doi: 10.1186/s12964-022-01017-9.
2
Compounding engineered mesenchymal stem cell-derived exosomes: A potential rescue strategy for retinal degeneration.工程化间充质干细胞衍生外泌体的制备:视网膜变性的潜在挽救策略。
Biomed Pharmacother. 2024 Apr;173:116424. doi: 10.1016/j.biopha.2024.116424. Epub 2024 Mar 11.
3
Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia.骨髓间充质干细胞来源的外泌体对再生障碍性贫血 T 细胞免疫抑制作用的损害。
Stem Cell Res Ther. 2023 Oct 4;14(1):285. doi: 10.1186/s13287-023-03496-0.
4
Dual impacts of mesenchymal stem cell-derived exosomes on cancer cells: unravelling complex interactions.间充质干细胞衍生外泌体对癌细胞的双重影响:揭示复杂的相互作用
J Cell Commun Signal. 2023 Dec;17(4):1229-1247. doi: 10.1007/s12079-023-00794-3. Epub 2023 Nov 16.
5
Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6/STAT3 pathway in macrophages.间充质干细胞来源的外泌体通过向巨噬细胞中的 KLF6/STAT3 途径递送 miR-148a 来防止肝纤维化。
Stem Cell Res Ther. 2022 Jul 20;13(1):330. doi: 10.1186/s13287-022-03010-y.
6
Therapeutic Potential of Exosomes Derived from Adipose Tissue-Sourced Mesenchymal Stem Cells in the Treatment of Neural and Retinal Diseases.脂肪组织源间充质干细胞衍生的外泌体在神经和视网膜疾病治疗中的治疗潜力。
Int J Mol Sci. 2022 Apr 19;23(9):4487. doi: 10.3390/ijms23094487.
7
Applications of Exosomal miRNAs from Mesenchymal Stem Cells as Skin Boosters.间充质干细胞来源的外泌体微小RNA作为皮肤增强剂的应用
Biomolecules. 2024 Apr 9;14(4):459. doi: 10.3390/biom14040459.
8
Exosomal miR-17-92 derived from human mesenchymal stem cells promotes wound healing by enhancing angiogenesis and inhibiting endothelial cell ferroptosis.源自人间充质干细胞的外泌体miR-17-92通过增强血管生成和抑制内皮细胞铁死亡促进伤口愈合。
Tissue Cell. 2023 Aug;83:102124. doi: 10.1016/j.tice.2023.102124. Epub 2023 May 29.
9
Hypoxic mesenchymal stem cell-derived exosomes promote bone fracture healing by the transfer of miR-126.低氧骨髓间充质干细胞来源的外泌体通过转移 miR-126 促进骨骨折愈合。
Acta Biomater. 2020 Feb;103:196-212. doi: 10.1016/j.actbio.2019.12.020. Epub 2019 Dec 17.
10
Exosomes derived from miR-92a-3p-overexpressing human mesenchymal stem cells enhance chondrogenesis and suppress cartilage degradation via targeting WNT5A.来源于 miR-92a-3p 过表达的人骨髓间充质干细胞的外泌体通过靶向 WNT5A 增强软骨生成并抑制软骨降解。
Stem Cell Res Ther. 2018 Sep 26;9(1):247. doi: 10.1186/s13287-018-1004-0.

引用本文的文献

1
Synergistic integration of extracellular vesicles and metal-organic frameworks: unlocking new opportunities in disease diagnosis and therapy.细胞外囊泡与金属有机框架的协同整合:为疾病诊断和治疗开启新机遇
Theranostics. 2025 Jul 28;15(16):8609-8638. doi: 10.7150/thno.113474. eCollection 2025.
2
From laboratory to clinic: a precise treatment strategy of mesenchymal stem cells-derived exosomes pretreated by simulating disease microenvironment.从实验室到临床:一种通过模拟疾病微环境预处理间充质干细胞衍生外泌体的精准治疗策略
Front Immunol. 2025 Jul 17;16:1609288. doi: 10.3389/fimmu.2025.1609288. eCollection 2025.
3

本文引用的文献

1
Mesenchymal Stem Cell Culture within Perfusion Bioreactors Incorporating 3D-Printed Scaffolds Enables Improved Extracellular Vesicle Yield with Preserved Bioactivity.灌注生物反应器中 3D 打印支架内的间充质干细胞培养可提高细胞外囊泡产量并保持生物活性。
Adv Healthc Mater. 2023 Aug;12(20):e2300584. doi: 10.1002/adhm.202300584. Epub 2023 Apr 2.
2
Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.靶向间质干细胞外泌体治疗微小 RNA-let-7c 递送来治疗去势抵抗性前列腺癌。
Front Biosci (Landmark Ed). 2022 Sep 6;27(9):256. doi: 10.31083/j.fbl2709256.
3
The therapeutic potential of exosomes in bone cancers: osteosarcoma, chondrosarcoma, and Ewing sarcoma.
外泌体在骨癌(骨肉瘤、软骨肉瘤和尤文肉瘤)中的治疗潜力。
Invest New Drugs. 2025 Jul 5. doi: 10.1007/s10637-025-01551-6.
4
Exosomal delivery of non-coding RNAs: a pathway to apoptosis regulation in lung cancer.外泌体介导的非编码RNA传递:肺癌细胞凋亡调控途径
Med Oncol. 2025 Jul 1;42(8):307. doi: 10.1007/s12032-025-02852-9.
5
AntagomiR-192-5p-engineered exosomes encapsulated in MXene-modified GelMA hydrogel facilitated epithelization of burn wounds by targeting OLFM4.包裹在MXene修饰的GelMA水凝胶中的抗miR-192-5p工程化外泌体通过靶向OLFM4促进烧伤创面上皮化。
Bioact Mater. 2025 Jun 11;52:318-337. doi: 10.1016/j.bioactmat.2025.06.013. eCollection 2025 Oct.
6
Small extracellular vesicles from human umbilical cord mesenchymal stem cells delivering miR-202-5p alleviate renal ischemia-reperfusion injury by targeting the GOLIM4/PI3K/AKT axis.来自人脐带间充质干细胞的小细胞外囊泡通过靶向GOLIM4/PI3K/AKT轴减轻肾缺血再灌注损伤。
Front Immunol. 2025 May 30;16:1586174. doi: 10.3389/fimmu.2025.1586174. eCollection 2025.
7
Diagnostic and therapeutic potential of oral cavity-derived exosomes in oral and maxillofacial tissue engineering: current advances and future perspectives.口腔来源外泌体在口腔颌面组织工程中的诊断和治疗潜力:当前进展与未来展望
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jun 10. doi: 10.1007/s00210-025-04316-3.
8
Exosomal miRNAs in pancreatitis: Mechanisms and potential applications (Review).胰腺炎中的外泌体微小RNA:机制与潜在应用(综述)
Mol Med Rep. 2025 Aug;32(2). doi: 10.3892/mmr.2025.13575. Epub 2025 May 26.
9
Exosome-Based Therapeutics in Dermatology.基于外泌体的皮肤病治疗方法
Biomater Res. 2025 May 9;29:0148. doi: 10.34133/bmr.0148. eCollection 2025.
10
Unleashing the Potential: Exploring the Application and Mechanism of Mesenchymal Stem Cells in Autoimmune Diseases.释放潜能:探索间充质干细胞在自身免疫性疾病中的应用及机制
Stem Cells Int. 2025 Apr 15;2025:9440377. doi: 10.1155/sci/9440377. eCollection 2025.
Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis.
间充质干细胞衍生外泌体的工程化:一种有前景的骨关节炎无细胞疗法
Membranes (Basel). 2022 Jul 28;12(8):739. doi: 10.3390/membranes12080739.
4
A Review of Molecular Interplay between Neurotrophins and miRNAs in Neuropsychological Disorders.神经递质与 microRNAs 在神经心理障碍中的分子相互作用综述。
Mol Neurobiol. 2022 Oct;59(10):6260-6280. doi: 10.1007/s12035-022-02966-5. Epub 2022 Aug 2.
5
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response.微小 RNA 可作为预测癌症患者对 SARS-CoV-2 感染和疫苗接种反应易感性的潜在工具。
Cells. 2022 Jul 23;11(15):2279. doi: 10.3390/cells11152279.
6
MicroRNAs as prognostic markers and therapeutic targets in gliomas.微小RNA作为胶质瘤的预后标志物和治疗靶点
Noncoding RNA Res. 2022 Jul 6;7(3):171-177. doi: 10.1016/j.ncrna.2022.07.001. eCollection 2022 Sep.
7
Prevention and Treatment of Monkeypox.猴痘的预防与治疗。
Drugs. 2022 Jun;82(9):957-963. doi: 10.1007/s40265-022-01742-y. Epub 2022 Jun 28.
8
Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022.2022 年 5 月,意大利四起猴痘病例的流行病学、临床和病毒学特征支持通过性接触传播。
Euro Surveill. 2022 Jun;27(22). doi: 10.2807/1560-7917.ES.2022.27.22.2200421.
9
Production of Mesenchymal Progenitor Cell-Derived Extracellular Vesicles in Suspension Bioreactors for Use in Articular Cartilage Repair.悬浮生物反应器中骨髓间充质祖细胞衍生的细胞外囊泡的生产用于关节软骨修复。
Stem Cells Transl Med. 2022 Mar 3;11(1):73-87. doi: 10.1093/stcltm/szab008.
10
A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system.脂质体作为靶向药物传递系统的最新进展的最新综述。
Int J Pharm. 2022 Aug 25;624:121878. doi: 10.1016/j.ijpharm.2022.121878. Epub 2022 May 28.